SPONSOR
Cedars-Sinai Medical Center
Total Trials
7
Recruiting
7
Phases
Phase 3, Phase 2
Conditions studied: Coronary AtherosclerosisGender DysphoriaMicrovascular Coronary DysfunctionTNBCTNBC - Triple-Negative Breast CancerEarly Stage Triple-Negative Breast CarcinomaPancreatic AdenocarcinomaWeight LossTakotsubo CardiomyopathyProstate Cancer
Cedars-Sinai Medical Center is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Coronary Atherosclerosis, Gender Dysphoria, Microvascular Coronary Dysfunction, TNBC.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Cedars-Sinai Medical Center
How many clinical trials has Cedars-Sinai Medical Center sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Cedars-Sinai Medical Center, of which 7 are actively recruiting participants. These trials cover conditions including Coronary Atherosclerosis, Gender Dysphoria, Microvascular Coronary Dysfunction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Cedars-Sinai Medical Center research focus on?
Cedars-Sinai Medical Center clinical trials span Coronary Atherosclerosis, Gender Dysphoria, Microvascular Coronary Dysfunction, TNBC, TNBC - Triple-Negative Breast Cancer, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Cedars-Sinai Medical Center clinical trial?
To participate in a Cedars-Sinai Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Cedars-Sinai Medical Center trials with current recruitment status updated daily.
Clinical Trials by Cedars-Sinai Medical Center
NCT03504956
Recruiting
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
Coronary Atherosclerosis
NCT04979338 Phase 3
Recruiting
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
Gender Dysphoria
NCT02301663
Recruiting
Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease
Microvascular Coronary Dysfunction
NCT07017673 Phase 2
Recruiting
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
TNBC
NCT06988150
Recruiting
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
Pancreatic Adenocarcinoma
NCT03910569
Recruiting
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Takotsubo Cardiomyopathy
NCT06856694
Recruiting
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology